Reply to F. Muntoni et al.: "In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy.

Clemens, Paula R; Hoffman, Eric P

Clemens, Paula R; Hoffman, Eric P.

Afiliação

Clemens PR; Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Hoffman EP; Research and Research Development, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA.

J Neuromuscul Dis ; 10(6): 1155-1157, 2023.

Article em En | MEDLINE | ID: mdl-37955094

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neuromuscul Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google